GSE48812 sulforaphane 3 v 10 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE48812_sulforaphane_3_v_10_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE48812_sulforaphane_3_v_10_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE48812_sulforaphane_3_v_10_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE48812_sulforaphane_3_v_10_human_up.

Results found

Linked to

 

Label

Description

 

Gene

multidrug resistance-related protein

Gene

LOXL1 antisense RNA 1

Gene

WASP family homolog 5, pseudogene

Gene

long intergenic non-protein coding RNA 632

Gene

embryonic stem cell related

Gene

long intergenic non-protein coding RNA 2582

Gene

long intergenic non-protein coding RNA 857

Gene

ring finger protein 216 pseudogene 1

Gene

ELFN1 antisense RNA 1

Gene

ZFHX4 antisense RNA 1

  • Gene

    multidrug resistance-related protein


  • Gene

    LOXL1 antisense RNA 1


  • Gene

    WASP family homolog 5, pseudogene


  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    embryonic stem cell related


  • Gene

    long intergenic non-protein coding RNA 2582


  • Gene

    long intergenic non-protein coding RNA 857


  • Gene

    ring finger protein 216 pseudogene 1


  • Gene

    ELFN1 antisense RNA 1


  • Gene

    ZFHX4 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.